Google+ Facebook Twitter Twitter

Concurrent dna and RNA sequencing testing

Research indicates adding RNA sequencing to germline genetic testing could improve accuracy and clinical sensitivity, compared to DNA sequencing alone.

In this study, which included 43,524 individuals undergoing hereditary cancer testing, RNA sequencing was associated with increased diagnostic positive yield and decreased inconclusive rate of multigene panel testing for germline cancer predisposition.

RNA-dependent classifications were made in 17.1% of splicing variants classified as pathogenic (1.9% of any variant classified as pathogenic), and 71.1% of splicing variants of uncertain significance (2.1% of any variants of uncertain significance) resolved as benign.

The authors concluded: “[The] findings of this diagnostic study demonstrate that the ability to perform RNA sequencing concurrently with DNA sequencing represents an important advancement in germline genetic testing.”

Image credit | Shutterstock

Related Articles

breast cancer cells - CREDIT - Science Photo Library-c0559159

Breast cancer cells’ self-sacrifice is potential cause of relapse

For patients with early-stage breast cancer, there is a 7% to 11% chance of relapse within five years after receiving initial treatment.

Specialist diploma in molecular pathology

On behalf of the members of the Molecular Pathology Advisory Panel, Chair Dr Andrew Blann introduces the new Specialist Diploma.

The role of organelle repair in fighting infection

Research has found that cellular structures act as “molecular plasters” that protect against infections, such as tuberculosis. We talk to study co-author Claudio Bussi.